ArticleEnvironmental health : a global access science source2017
Comments on "Incidence of cancer among licensed commercial pilots flying North Atlantic routes".
Article in Environmental health : a global access science source, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 2 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
- Comment on
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gudmundsdottir et al. in their paper entitled "Incidence of cancer among licensed commercial pilots flying North Atlantic routes" published in Environmental Health have evaluated the effects of exposure to higher levels of cosmic radiation on cancer incidence in the pilots of commercial flights. Despite its remarkable strengths, the paper authored by Gudmundsdottir et al. has some shortcomings. The shortcomings of this paper such as not determining the shape of dose-response relationship for radiation-induced cancers, limitations in flight dose calculations, the weaknesses of CARI-6 as the program used by Gudmundsdottir et al. to estimate the effective dose of galactic cosmic rays, and the problems associated with unpredictable nature of the magnitude and duration of solar particle events are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.